Genesis Therapeutics has secured $200 million funding from NVentures, NVIDIA’s venture capital arm. This forms part of an ...

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

Pharmacokinetic (PK) tests form an integral part of the drug development process, helping to ensure the safety and efficacy ...

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

Innovative radiotherapy offers a precision treatment alternative.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.